Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
Notified -
Globe Newswire25-02-2026, 07:30
At its Capital Markets Day, Iveco Group updated its guidance for 2024 and presented the financial targets for the duration of the Plan 15-03-2024, 13:30